Process for the production of biaryl compounds

US10040732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10040732-B2
Application numberUS-201515326860-A
CountryUS
Kind codeB2
Filing dateJul 15, 2015
Priority dateJul 17, 2014
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Process for producing biaryl compounds by aerobic cross dehydrogenative coupling (CDC) of two arene groups comprising at least one aryl carbon-hydrogen bond, in the presence of a catalyst system comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion and one or more non-beta-eliminatable, non-cyclopalladatable ligands comprising at least one N-donor atom, the one or more ligands having a 0.5/1-1.5/1 molar ratio of N-donor atoms relative to the Pd atoms.

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for producing biaryl compounds by aerobic cross dehydrogenative coupling (CDC) of two arene groups comprising at least one aryl carbon-hydrogen bond, in the presence of a catalyst system comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion and one or more non-beta-eliminatable, non-cyclopalladatable ligands comprising at least one N-donor atom, the one or more ligands having a 0.5/1-1.5/1 molar ratio of N-donor atoms relative to the Pd atoms. 2. Process according to claim 1 , wherein the molar ratio of N-donor atoms relative to the Pd atoms is between 0.7/1 and 1.3/1. 3. Process according to claim 1 , wherein the molar ratio of N-donor atoms relative to the Pd atoms is between 0.8/1 and 1.2/1. 4. Process according to claim 1 , wherein aliphatic cyclic or non-cyclic primary, secondary or tertiary amines, aromatic N-heterocycles and/or benzofused derivatives thereof are used as the one or more ligands. 5. Process according to claim 4 , wherein pyridines, pyridazines, pyrimidines, pyrazines, triazines, imidazoles, triazoles, oxazoles, 4,5-dihydrooxazoles, isoxazoles, 4,5-dihydroisoxazoles, and 5,6-dihydro-4H-1,3-oxazines or quinolines, isoquinolines, cinnolines, phthalazines, quinazoline, quinoxalines, 1H-benzo[d]imidazoles, 1H-benzo[d][1,2,3]triazoles, benzo[d]oxazoles, benzo[d]isoxazoles and 4H-benzo[e][1,3]oxazines and/or benzofused derivatives thereof are used as the one or more ligands. 6. Process according to claim 4 , wherein pyridines, pyridazines, pyrimidines, pyrazines, triazines, quinolines, isoquinolines, cinnolines, phthalazine, quinazoline, and quinoxalines and/or benzofused derivatives thereof are used as the one or more ligands. 7. Process according to claim 1 , wherein the process is carried out under a (partial) pressure of oxygen of 0.2-2 bar, and wherein a catalyst system is used comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion derived from a carboxylic acid that is triply substituted at the alpha-carbon atom relative to the carboxylate group, with the carboxylic acid also containing at least one beta-carbon atom. 8. Process according to claim 7 , wherein the carboxylate anion is derived from a 2,2-dialkylalkanoic acid, 2-fluoro-2-alkylalkanoic acid, 2,2-difluoroalkanoic acid, 2,2-difluoro-2-arylacetic acid, with the alkanoic acid containing at least one beta-carbon atom. 9. Process according to claim 7 , wherein the carboxylate anion is derived from pivalic acid, 3,3,3-trifluoro-2-methyl-2-(trifluoromethyl)propanoic acid, 3,3,3-trifluoro-2,2-bis(trifluoromethyl)propanoic acid, and 2,2-difluoro-2-phenylacetic acid. 10. Process according to claim 1 , wherein the process is carried out under a (partial) pressure of oxygen of 0.2-2 bar, and wherein a catalyst system is used comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion derived from a carboxylic acid with an acidity constant in between that of acetic acid and 2,2,2-trifluoroacetic acid, with aforementioned acidity constant meaning the acidity constant average (pK a acid 1 +pK a acid 2 )/2 in case of two different carboxylate anions. 11. Process according to claim 10 , wherein the carboxylate anion is derived from 2,2-difluoroacetic acid, 2,2-difluoropropionic acid, 3,3,3-trifluoro-2-methyl-2-(trifluoromethyl)propanoic acid, 3,3,3-trifluoro-2,2-bis(trifluoromethyl)propanoic acid, 2,3,4,5,6-pentafluorobenzoic acid, 2,2-difluoro-2-phenylacetic acid, 2-(2,3,4,5,6-pentafluorophenyl)acetic acid 2,4-dinitrobenzoic acid, 2,5-dinitrobenzoic acid, and 3,4-dinitrobenzoic acid. 12. Process according to claim 1 , wherein the process is carried out under a (partial) pressure of oxygen of 2-20 bar, and wherein a catalyst system is used comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion derived from a strongly acidic carboxylic acid, i.e. with an acidity constant that is equal or less than the acidity constant average of acetic acid and 2,2,2-trifluoroacetic acid, with aforementioned acidity constant average being quantified as (pK a acetic acid +pK a trifluoroacetic acid )/2. 13. Process according to claim 12 , wherein the carboxylate anion is derived from trifluoroacetic acid, 3,3,3-trifluoro-2,2-bis(trifluoromethyl)propanoic acid, 3,3,3-trifluoro-2-(trifluoromethyl)propanoic acid, and 2,2-difluoro-2-phenylacetic acid. 14. Process according to claim 1 , wherein at most 50 wt % of solvent is used, based on the total reaction mass. 15. Process according to claim 1 , wherein at most 10 wt % of solvent is used, based on the total reaction mass.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10040732B2 cover?
Process for producing biaryl compounds by aerobic cross dehydrogenative coupling (CDC) of two arene groups comprising at least one aryl carbon-hydrogen bond, in the presence of a catalyst system comprising a palladium salt comprising at least one non-cyclopalladatable carboxylate anion and one or more non-beta-eliminatable, non-cyclopalladatable ligands comprising at least one N-donor atom, the…
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C07C2/84. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).